InvestorsHub Logo
Followers 14
Posts 698
Boards Moderated 0
Alias Born 04/06/2011

Re: Walk22 post# 9351

Saturday, 05/16/2020 3:38:50 PM

Saturday, May 16, 2020 3:38:50 PM

Post# of 16706
The discussion of moving forward with other Drugs reminded me of this post. 36% suffering Kidney issues.
Well AGN (NASH?) has been / is researching CKD specific Drugs and also NASH / IBD drugs. There appears to be a increased demand for treatments developing so maybe our guys have identified something, maybe like the NDMA response being tested in Ifenprodil. Maybe even applying for Rights to specific uses as they did with Ifenprodil with some of the raised Ca$h. Maybe pushing Forward with Trials of other Drugs, seems logical...GLTA...

Nice find, walk22...

https://news.google.com/articles/CBMid2h0dHBzOi8vdGhlaGlsbC5jb20vcG9saWN5L2hlYWx0aGNhcmUvNDk3NzE1LWtpZG5leS1kYW1hZ2Utc2Vlbi1pbi1vbmUtdGhpcmQtb2YtY292aWQtMTktcGF0aWVudHMtc3R1ZGllZC1pbi1uZXctcmVwb3J00gF7aHR0cHM6Ly90aGVoaWxsLmNvbS9wb2xpY3kvaGVhbHRoY2FyZS80OTc3MTUta2lkbmV5LWRhbWFnZS1zZWVuLWluLW9uZS10aGlyZC1vZi1jb3ZpZC0xOS1wYXRpZW50cy1zdHVkaWVkLWluLW5ldy1yZXBvcnQ_YW1w?hl=en-US&gl=US&ceid=US%3Aen

Having NASH contribute something to AGN would be nice...JMH(misguided)O...